Omeros makes new appointment
This article was originally published in Scrip
Executive Summary
Omeros, a US clinical-stage biopharmaceutical company discovering, developing and commercialising products focused on inflammation and disorders of the central nervous system, has named Dr Stephen Murray vice-president of clinical development. Dr Murray most recently served as chief medical officer at Memory Pharmaceuticals, a biopharmaceutical company that was acquired by Roche in January.